Terms: = Prostate cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Treatment
216 results:
1. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
2. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
Jin R; Forbes CM; Miller NL; Lafin J; Strand DW; Case T; Cates JM; Liu Q; Ramirez-Solano M; Mohler JL; Matusik RJ
Prostate; 2024 Apr; 84(5):441-459. PubMed ID: 38168866
[TBL] [Abstract] [Full Text] [Related]
3.
Giordano F; Comità S; Venneri G; Rago V; Naimo GD; De Amicis F; De Bartolo A; Tundis R; Mauro L; Panno ML
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003541
[TBL] [Abstract] [Full Text] [Related]
4. The Network Pharmacology Analysis of Tonifying Yang Formula for the treatment of Diminished Ovarian Reserve.
Ma Q; Wu X; Chen D; Li W; Wu J; Shen M; Ye C; Tan Y; Guo Q
Altern Ther Health Med; 2024 Mar; 30(3):176-184. PubMed ID: 37883761
[TBL] [Abstract] [Full Text] [Related]
5. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
6. MKK4 Inhibitors-Recent Development Status and Therapeutic Potential.
Katzengruber L; Sander P; Laufer S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108658
[TBL] [Abstract] [Full Text] [Related]
7. The ethanol extract of Cyperus exaltatus var. iwasakii exhibits cell cycle dysregulation, ERK1/2/p38 MAPK/AKT phosphorylation, and reduced MMP-9-mediated metastatic capacity in prostate cancer models in vitro and in vivo.
Kim H; Hwang B; Cho S; Kim WJ; Myung SC; Choi YH; Kim WJ; Lee S; Moon SK
Phytomedicine; 2023 Jun; 114():154794. PubMed ID: 37011419
[TBL] [Abstract] [Full Text] [Related]
8. Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma.
Sadeghi R; Pirankuraim H; Javanshir ST; Arabi M; Bereimipour A; Javanshir HT; Mahmoodzadeh H; Nayernia K
Eye (Lond); 2023 Aug; 37(11):2327-2334. PubMed ID: 36528757
[TBL] [Abstract] [Full Text] [Related]
9. The effect of lycopene supplement from different sources on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials.
Sharifi-Zahabi E; Soltani S; Malekahmadi M; Rezavand L; Clark CCT; Shidfar F
Complement Ther Med; 2022 Mar; 64():102801. PubMed ID: 35031434
[TBL] [Abstract] [Full Text] [Related]
10. The role of N-cadherin/c-jun/NDRG1 axis in the progression of prostate cancer.
Quan Y; Zhang X; Butler W; Du Z; Wang M; Liu Y; Ping H
Int J Biol Sci; 2021; 17(13):3288-3304. PubMed ID: 34512147
[TBL] [Abstract] [Full Text] [Related]
11. Application of network pharmacology and molecular docking to elucidate the potential mechanism of Astragalus-Scorpion against prostate cancer.
Wu L; Chen Y; Chen M; Yang Y; Che Z; Li Q; You X; Fu W
Andrologia; 2021 Oct; 53(9):e14165. PubMed ID: 34185887
[TBL] [Abstract] [Full Text] [Related]
12. In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit jun.
Riedel M; Berthelsen MF; Cai H; Haldrup J; Borre M; Paludan SR; Hager H; Vendelbo MH; Wagner EF; Bakiri L; Thomsen MK
Oncogene; 2021 Apr; 40(13):2437-2447. PubMed ID: 33674748
[TBL] [Abstract] [Full Text] [Related]
13. MRI predicts prostatic urethral involvement in men undergoing radical prostatectomy: implications for cryo-ablation of localized prostate cancer.
Becher E; Sali A; Abreu A; Iwata T; Tong A; Deng FM; Iwata A; Gupta C; Gill I; Aron M; Palmer S; Lepor H
World J Urol; 2021 Sep; 39(9):3309-3314. PubMed ID: 33616707
[TBL] [Abstract] [Full Text] [Related]
14. Retzius Sparing prostatectomy Effect on Symptomatic Lymphocele Rates.
Wong D; Rincon J; Henning G; Smith Z; Kim E
Urology; 2021 Mar; 149():129-132. PubMed ID: 33279613
[TBL] [Abstract] [Full Text] [Related]
15. Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve Injury.
Yin GN; Ock J; Limanjaya A; Minh NN; Hong SS; Yang T; Longo FM; Ryu JK; Suh JK
J Sex Med; 2021 Jan; 18(1):17-28. PubMed ID: 33243690
[TBL] [Abstract] [Full Text] [Related]
16. Identification of key genes and pathways in IgA nephropathy using bioinformatics analysis.
Hu SL; Wang D; Yuan FL; Lei QF; Zhang Y; Cheng JZ
Medicine (Baltimore); 2020 Jul; 99(30):e21372. PubMed ID: 32791747
[TBL] [Abstract] [Full Text] [Related]
17. Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer properties.
Dyshlovoy SA; Kaune M; Kriegs M; Hauschild J; Busenbender T; Shubina LK; Makarieva TN; Hoffer K; Bokemeyer C; Graefen M; Stonik VA; von Amsberg G
Sci Rep; 2020 Aug; 10(1):13178. PubMed ID: 32764580
[TBL] [Abstract] [Full Text] [Related]
18. TNF-α controls Lipocalin-2 expression in PC-3 prostate cancer cells.
Schröder SK; Asimakopoulou A; Tillmann S; Koschmieder S; Weiskirchen R
Cytokine; 2020 Nov; 135():155214. PubMed ID: 32712458
[TBL] [Abstract] [Full Text] [Related]
19. Paclitaxel induces apoptosis through the TAK1-JNK activation pathway.
Yu-Wei D; Li ZS; Xiong SM; Huang G; Luo YF; Huo TY; Zhou MH; Zheng YW
FEBS Open Bio; 2020 Aug; 10(8):1655-1667. PubMed ID: 32594651
[TBL] [Abstract] [Full Text] [Related]
20. Neferine treatment enhances the TRAIL‑induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway.
Nazim UM; Yin H; Park SY
Int J Oncol; 2020 May; 56(5):1152-1161. PubMed ID: 32319589
[TBL] [Abstract] [Full Text] [Related]
[Next]
